Sodium Bicarbonate → N-[1-(4-Chloro-3-fluorobenzyl)-4-piperidinyl]-3-[3-(2-pyridinyl)-1,2,4-oxadiazol-5-yl]propanamide
Reaction equation
[N:1]1[CH:6]=[CH:5][CH:4]=[CH:3][C:2]=1[C:7]1[N:11]=[C:10]([CH2:12][CH2:13][C:14]([OH:16])=O)[O:9][N:8]=1.[Cl:17][C:18]1[CH:31]=[CH:30][C:21]([CH2:22][N:23]2[CH2:28][CH2:27][CH:26]([NH2:29])[CH2:25][CH2:24]2)=[CH:20][C:19]=1[F:32].C(=O)([O-])O.[Na+]>ClCCl>[Cl:17][C:18]1[CH:31]=[CH:30][C:21]([CH2:22][N:23]2[CH2:28][CH2:27][CH:26]([NH:29][C:14](=[O:16])[CH2:13][CH2:12][C:10]3[O:9][N:8]=[C:7]([C:2]4[CH:3]=[CH:4][CH:5]=[CH:6][N:1]=4)[N:11]=3)[CH2:25][CH2:24]2)=[CH:20][C:19]=1[F:32]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
3-[3-(2-Pyridinyl)-1,2,4-oxadiazol-5-yl]propanoic acid (0.136 g) and N,N′-carbonyldiimidazole (0.114 g) were stirred in dichloromethane (10 ml) under nitrogen for 1 hour. 1-(4-Chloro-3-fluorobenzyl)-4-piperidinamine (0.150 g) was then added and left to stir for 2 hours. Saturated sodium hydrogen carbonate was added to the reaction, with the resulting solution being extracted three times with dichloromethane. The pooled organic phases were washed once with water, once with brine, dried over magnesium sulfate, filtered and the solvent removed under reduced pressure to leave an oil. This was triturated with diethyl ether which caused product the to crystallise. After filtration, the product was washed with diethyl ether and dried to N-[1-(4-chloro-3-fluorobenzyl)-4-piperidinyl]-3-[3-(2-pyridinyl)-1,2,4-oxadiazol-5-yl]propanamide. m.p. 132° C.
Workup
- waitleft
- extractionbeing extracted three times with dichloromethane
- washThe pooled organic phases were washed once with water, once with brine
- dry with materialdried over magnesium sulfate
- filtrationfiltered
- customthe solvent removed under reduced pressure
- customto leave an oil
- customThis was triturated with diethyl ether which
- customto crystallise
- filtrationAfter filtration
- washthe product was washed with diethyl ether
- dry with materialdried to N-[1-(4-chloro-3-fluorobenzyl)-4-piperidinyl]-3-[3-(2-pyridinyl)-1,2,4-oxadiazol-5-yl]propanamide
Sources & evidence
- ORD record
- ord-58379b9279144aaeacbf622b872cb3d4
- Source dataset
- uspto-grants-2005_06
- Patent number
- US06903085B1
Reaction notes
Loading…